DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 559.6 Million USD | 82.46% |
| 2022 | 306.7 Million USD | -14.16% |
| 2021 | 357.3 Million USD | 52.24% |
| 2020 | 234.7 Million USD | 95.91% |
| 2019 | 119.8 Million USD | 69.45% |
| 2018 | 70.7 Million USD | 56.42% |
| 2017 | 45.2 Million USD | -0.44% |
| 2016 | 45.4 Million USD | 28.98% |
| 2015 | 35.2 Million USD | 120.0% |
| 2014 | 16 Million USD | 77.78% |
| 2013 | 9 Million USD | 21.62% |
| 2012 | 7.4 Million USD | -9.44% |
| 2011 | 8.17 Million USD | 0.73% |
| 2010 | 8.11 Million USD | 207.16% |
| 2009 | 2.64 Million USD | 7.97% |
| 2008 | 2.44 Million USD | 114.75% |
| 2007 | 1.13 Million USD | -19.39% |
| 2006 | 1.41 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 586.3 Million USD | 2.81% |
| 2024 Q1 | 589.1 Million USD | 5.27% |
| 2024 Q2 | 570.3 Million USD | -3.19% |
| 2023 FY | 559.6 Million USD | 82.46% |
| 2023 Q4 | 559.6 Million USD | 12.23% |
| 2023 Q2 | 421.1 Million USD | 15.05% |
| 2023 Q1 | 366 Million USD | 19.33% |
| 2023 Q3 | 498.6 Million USD | 18.4% |
| 2022 Q1 | 342.2 Million USD | -4.23% |
| 2022 FY | 306.7 Million USD | -14.16% |
| 2022 Q2 | 339.5 Million USD | -0.79% |
| 2022 Q3 | 311 Million USD | -8.39% |
| 2022 Q4 | 306.7 Million USD | -1.38% |
| 2021 Q1 | 289.7 Million USD | 23.43% |
| 2021 Q2 | 319.3 Million USD | 10.22% |
| 2021 Q3 | 351.3 Million USD | 10.02% |
| 2021 Q4 | 357.3 Million USD | 1.71% |
| 2021 FY | 357.3 Million USD | 52.24% |
| 2020 Q3 | 200.7 Million USD | 21.42% |
| 2020 Q1 | 141.9 Million USD | 18.45% |
| 2020 Q2 | 165.3 Million USD | 16.49% |
| 2020 Q4 | 234.7 Million USD | 16.94% |
| 2020 FY | 234.7 Million USD | 95.91% |
| 2019 FY | 119.8 Million USD | 69.45% |
| 2019 Q4 | 119.8 Million USD | -0.5% |
| 2019 Q3 | 120.4 Million USD | 2.12% |
| 2019 Q2 | 117.9 Million USD | 16.62% |
| 2019 Q1 | 101.1 Million USD | 43.0% |
| 2018 Q1 | 51.6 Million USD | 14.16% |
| 2018 Q3 | 55.2 Million USD | 19.48% |
| 2018 Q4 | 70.7 Million USD | 28.08% |
| 2018 FY | 70.7 Million USD | 56.42% |
| 2018 Q2 | 46.2 Million USD | -10.47% |
| 2017 Q2 | 42.8 Million USD | -7.96% |
| 2017 Q4 | 45.2 Million USD | 4.39% |
| 2017 FY | 45.2 Million USD | -0.44% |
| 2017 Q1 | 46.5 Million USD | 2.42% |
| 2017 Q3 | 43.3 Million USD | 1.17% |
| 2016 Q4 | 45.4 Million USD | 1.57% |
| 2016 FY | 45.4 Million USD | 28.98% |
| 2016 Q3 | 44.7 Million USD | 4.2% |
| 2016 Q2 | 42.9 Million USD | -6.94% |
| 2016 Q1 | 46.1 Million USD | 30.97% |
| 2015 Q2 | 22.4 Million USD | 21.74% |
| 2015 Q3 | 30.6 Million USD | 36.61% |
| 2015 Q4 | 35.2 Million USD | 15.03% |
| 2015 FY | 35.2 Million USD | 120.0% |
| 2015 Q1 | 18.4 Million USD | 15.0% |
| 2014 FY | 16 Million USD | 77.78% |
| 2014 Q2 | 11.6 Million USD | 30.34% |
| 2014 Q3 | 14.3 Million USD | 23.28% |
| 2014 Q4 | 16 Million USD | 11.89% |
| 2014 Q1 | 8.9 Million USD | -1.11% |
| 2013 Q4 | 9 Million USD | -10.0% |
| 2013 Q3 | 10 Million USD | 36.99% |
| 2013 FY | 9 Million USD | 21.62% |
| 2013 Q2 | 7.3 Million USD | -2.67% |
| 2013 Q1 | 7.5 Million USD | 1.35% |
| 2012 Q3 | 7.14 Million USD | -3.21% |
| 2012 Q4 | 7.4 Million USD | 3.63% |
| 2012 Q2 | 7.37 Million USD | -8.28% |
| 2012 Q1 | 8.04 Million USD | -1.55% |
| 2012 FY | 7.4 Million USD | -9.44% |
| 2011 Q1 | 6.42 Million USD | -20.8% |
| 2011 Q3 | 6.45 Million USD | 3.15% |
| 2011 Q4 | 8.17 Million USD | 26.58% |
| 2011 FY | 8.17 Million USD | 0.73% |
| 2011 Q2 | 6.25 Million USD | -2.6% |
| 2010 Q4 | 8.11 Million USD | 27.69% |
| 2010 Q1 | 3.85 Million USD | 45.82% |
| 2010 FY | 8.11 Million USD | 207.16% |
| 2010 Q2 | 4.08 Million USD | 6.13% |
| 2010 Q3 | 6.35 Million USD | 55.44% |
| 2009 FY | 2.64 Million USD | 7.97% |
| 2009 Q3 | 1.93 Million USD | 41.75% |
| 2009 Q4 | 2.64 Million USD | 36.7% |
| 2009 Q2 | 1.36 Million USD | -42.37% |
| 2009 Q1 | 2.36 Million USD | -3.31% |
| 2008 Q1 | 1.82 Million USD | 60.14% |
| 2008 FY | 2.44 Million USD | 114.75% |
| 2008 Q2 | 2.77 Million USD | 51.92% |
| 2008 Q4 | 2.44 Million USD | -5.56% |
| 2008 Q3 | 2.59 Million USD | -6.53% |
| 2007 Q2 | 1.25 Million USD | -13.93% |
| 2007 Q4 | 1.13 Million USD | 10.05% |
| 2007 FY | 1.13 Million USD | -19.39% |
| 2007 Q1 | 1.45 Million USD | 3.11% |
| 2007 Q3 | 1.03 Million USD | -17.46% |
| 2006 Q2 | 3.2 Million USD | 67.11% |
| 2006 Q3 | 1.93 Million USD | -39.61% |
| 2006 FY | 1.41 Million USD | 0.0% |
| 2006 Q4 | 1.41 Million USD | -27.06% |
| 2006 Q1 | 1.91 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -16806.344% |
| BrainsWay Ltd. | 3.71 Million USD | -14955.152% |
| Cerus Corporation | 39.86 Million USD | -1303.632% |
| Envoy Medical, Inc. | 1.4 Million USD | -39757.55% |
| electroCore, Inc. | 2.16 Million USD | -25807.407% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -122350.766% |
| IceCure Medical Ltd | 2.27 Million USD | -24497.802% |
| Inogen, Inc. | 21.84 Million USD | -2462.271% |
| OrthoPediatrics Corp. | 105.85 Million USD | -428.668% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -201194.964% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -55959999900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -4476.008% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -32308.904% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -357654.763% |
| Orthofix Medical Inc. | 222.16 Million USD | -151.884% |
| PAVmed Inc | 1.01 Million USD | -54924.636% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -2703.467% |
| RxSight, Inc. | 17.42 Million USD | -3112.215% |
| Sight Sciences, Inc. | 7.84 Million USD | -7029.571% |
| SI-BONE, Inc. | 20.24 Million USD | -2663.593% |
| TELA Bio, Inc. | 13.16 Million USD | -4151.633% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -1813.489% |
| Vivos Therapeutics, Inc. | 1.00 USD | -55959999900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -12980.879% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -243204.348% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -23652.122% |
| CVRx, Inc. | 10.98 Million USD | -4995.147% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -143359.223% |
| Bioventus Inc. | 91.33 Million USD | -512.703% |
| Venus Concept Inc. | 28.67 Million USD | -1851.458% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -21888.212% |
| LivaNova PLC | 147.88 Million USD | -278.397% |
| 908 Devices Inc. | 14.93 Million USD | -3646.151% |
| Alphatec Holdings, Inc. | 136.84 Million USD | -308.939% |
| Nemaura Medical Inc. | 1.75 Million USD | -31788.729% |
| NeuroPace, Inc. | 11.21 Million USD | -4890.191% |
| LENSAR, Inc. | 15.68 Million USD | -3466.83% |
| Apyx Medical Corporation | 9.92 Million USD | -5539.424% |
| Cutera, Inc. | 72.1 Million USD | -676.133% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -20835.279% |
| BioSig Technologies, Inc. | -103 Thousand USD | 543400.971% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -1106.398% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -6973.695% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | -43.632% |
| Axonics, Inc. | 79.94 Million USD | -600.025% |
| Outset Medical, Inc. | 49.21 Million USD | -1037.052% |
| IRIDEX Corporation | 9.9 Million USD | -5549.102% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -1307.586% |
| IRadimed Corporation | 12.82 Million USD | -4264.648% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -73921.164% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -211463.399% |
| Telesis Bio, Inc. | 4.02 Million USD | -13803.106% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -12053.801% |
| Varex Imaging Corporation | 277.5 Million USD | -101.658% |
| Quipt Home Medical Corp. | 18.32 Million USD | -2953.628% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -3242.293% |
| Dynatronics Corporation | 5.59 Million USD | -9903.622% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -14858.567% |
| Semler Scientific, Inc. | 445 Thousand USD | -125652.809% |
| InMode Ltd. | 45.09 Million USD | -1140.936% |
| Bruker Corporation | 968.3 Million USD | 42.208% |
| Cytosorbents Corporation | 3.68 Million USD | -15105.989% |
| Align Technology, Inc. | 296.9 Million USD | -88.48% |
| Viveve Medical, Inc. | 1.47 Million USD | -37916.304% |
| ZimVie Inc. | 79.6 Million USD | -603.015% |
| Movano Inc. | 1.51 Million USD | -36886.12% |
| Cytek Biosciences, Inc. | 60.87 Million USD | -819.231% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -357654.763% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | -254.318% |
| Profound Medical Corp. | 6.95 Million USD | -7948.044% |
| Insulet Corporation | 402.6 Million USD | -38.997% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -3671.144% |
| iCAD, Inc. | 917 Thousand USD | -60925.082% |
| Nuwellis, Inc. | 1.99 Million USD | -27922.033% |
| Biotricity, Inc. | 1.87 Million USD | -29675.429% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -3904.867% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -26471.7% |
| PAVmed Inc. | 1.01 Million USD | -54924.636% |
| BIOLASE, Inc. | 11.43 Million USD | -4794.603% |
| Beyond Air, Inc. | 2.12 Million USD | -26209.356% |
| FONAR Corporation | 2.71 Million USD | -20508.071% |
| AxoGen, Inc. | 23.02 Million USD | -2330.93% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -2384.13% |
| Inari Medical, Inc. | 42.9 Million USD | -1204.429% |
| UFP Technologies, Inc. | 70.19 Million USD | -697.253% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -88841.303% |
| Tenon Medical, Inc. | 554 Thousand USD | -100910.83% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -33515.162% |
| AdaptHealth Corp. | 113.64 Million USD | -392.424% |
| Sintx Technologies, Inc. | 888 Thousand USD | -62918.018% |
| NanoVibronix, Inc. | 2.73 Million USD | -20383.163% |
| Quanterix Corporation | 22.36 Million USD | -2402.124% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -3669.112% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | -887.367% |
| TransMedics Group, Inc. | 44.23 Million USD | -1165.062% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -9799.169% |
| NeuroMetrix, Inc. | 1.55 Million USD | -35784.953% |
| Hyperfine, Inc. | 6.58 Million USD | -8401.975% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | -600.034% |
| Biomerica, Inc. | 2.37 Million USD | -23452.189% |
| Bone Biologics Corporation | -328.84 Thousand USD | 170271.875% |
| AVITA Medical, Inc. | 3.12 Million USD | -17827.784% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -1773.075% |